Healthcare Global Enterprises Share Price

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company provides fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Triesta brand offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company operates a comprehensive cancer care center in Indore, Madhya Pradesh. It is also engaged in the radiation business in Indore, Madhya Pradesh. Its multispecialty hospitals deliver tertiary care for cardiac, bone and joint, brain, and spine.As of 28 Jun 2026, Healthcare Global Enterprises share price is ₹600.40. The stock opened at ₹614.40, compared to its previous close of ₹614.20. During today's trading session, Healthcare Global Enterprises share price moved in the range of ₹597.15 to ₹616.50, with an average price of ₹606.83 for the day. Looking at its last 52-week, the stock has touched a low of ₹597.15 and a high of ₹616.50. On the performance front, Healthcare Global Enterprises share price has declined by 11.40% over the last six months and is up 11.09% on a year-on-year basis.

The market capitalization of Healthcare Global Enterprises is ₹8,980 Crs, with a P/E ratio of 393.1 and a dividend yield of 0.00%.